Effect of Ximelagatran and Warfarin on Stroke Subtypes in Atrial Fibrillation

Canadian Journal of Neurological Sciences - United Kingdom
doi 10.1017/s031716710000857x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin

Archives of Internal Medicine
2006English

Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and v Clinical Trials

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2007English

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Stroke and Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2015English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation

American Journal of Kidney Diseases
Nephrology
2017English

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

Stroke and Thromboembolism in Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes

Canadian Journal of Kidney Health and Disease
Nephrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy